Atlas Trials

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Clinical trial NCT00448292 · COMPLETED

Trial details

NCT number
NCT00448292
Sponsor
Epix Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder (MDD)
Start date
2007-03-01
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.